Pursuant to the provisions of the Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), IOL Chemicals and Pharmaceuticals has informed that the Board of Directors of the Company, at their Meeting held today 28th October 2024,approved the following: 1. Appointment of Rajni Jha (DIN: 10818947) as an Additional and Independent Director of the Company for a term of three years, with effect from 28th October 2024, subject to approval of Members of the Company. The details as required under Regulation 30 of the Listing Regulations read with SEBI Circular dated 13th July 2023 are enclosed as ‘Annexure A’. Pursuant to the BSE and NSE circulars dated 20th June 2018, it has affirmed that Rajni Jha is not debarred from holding office of a director by virtue of any order of the Securities and Exchange Board of India or any other such authority. 2. Approved the Postal Ballot Notice to seek the approval of the shareholders through Postal Ballot for appointment of Rajni Jha as Independent Director of the Company. Postal Ballot Notice shall be sent to the shareholders in due course and the same shall be filed with the exchanges. The Board also reconstituted the Nomination & Remuneration Committee and Stakeholders’ Relationship Committee of the Board. The meeting commenced at 11:00 am and concluded at 12.05 pm. The above information will be made available on the website of the Company at www.iolcp.com.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: